Clinical Study

Summary

Hypertension is known to be the major risk factor for stroke. The most common cause of secondary hypertension, primary aldosteronism (PA), is characterized by the excessive secretion of aldosterone and is related to hypertension and hypokalemia. PA accounts for 3-10% of hypertensive patients, and a higher incidence of vascular complications compared to patients with essential hypertension was observed in several studies. The vascular injury from excessive aldosterone can occur via oxidative stress and collagen remodeling, causing endothelial dysfunction and fibrosis in the vasculature.The association between cerebral small vessel disease (cSVD) and hypertension has been well studied in the past decades. However, not much study has focused on the cSVD burden inpatient with PA. The goal of this study is to understand the features of cSVD in patients with PA and for the purpose of understanding the underlying pathophysiology ofcerebrovascular injury in this particular patient group.

Study Name: Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism
Status: Unknown
Conditions: Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism
Interventions: Diagnostic Test: Brain MRI
Locations: Bei-Hu Branch, National Taiwan University Hospital, Taipei, Taiwan
Study link: https://ClinicalTrials.gov/show/NCT03821571

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.